Aromics

MainImage

286,945.27€

Out of 300,000.00€

investors

35

Est. ROI

614%

days left

2

Developing a novel treatment for malignant mesothelioma

Finish date: 31/03/2017 Barcelona

Premoney valuation

5,000,000.00€

Percentage offered

5.66%

Est. ROI

614%

Exit horizon

2021